Effect Of Melissa Officinalis Capsule On The Mental Health Of Female Adolescents With Premenstrual Syndrome: A Clinical Trial Study
Notes for this study:
||Table 2, small, significant improvements for each.
|Number of Subjects
||7-12, 13-17, 18-29
In a randomized, double-blind, placebo-controlled trial, 100 girls with premenstrual syndrome were allocated to take 1,200 mg of M. officinalis or placebo daily during their menstrual periods for 3 cycles. Scores on the The General Health Questionnaire, symptoms were significantly lower for the intervention group for psychosomatic symptoms, anxiety and sleep disturbances, social function disturbance, and depression.